All Work

Chris Lange

FibroGen Prices Follow-On Offering

Shares of FibroGen saw a handy gain on Wednesday after the biopharmaceutical company announced the pricing of its underwritten follow-on offering.

Chris Lange · 9 years ago

Is This the Turnaround That Urban Outfitters Was Looking For?

Urban Outfitters, Inc. (NASDAQ: URBN) reported its fiscal second quarter financial results after the markets closed on Tuesday. The retailer said that it had $0.44 in earnings per share (EPS) and $872.9 million in…

Chris Lange · 9 years ago

Tuesday’s Biggest Winners and Losers in the S&P 500

Tuesday was a relatively flat day for the U.S. broad markets. There wasn’t much, if any, change in the price of crude oil. Most of the significant moves that happened on Tuesday were earnings…

Chris Lange · 9 years ago

Can Target Buck This Retail Trend With Earnings?

Like many other companies in the retail sector, Target has been left bloody and battered It is scheduled to release its fiscal second-quarter financial results before the markets open on Wednesday.

Chris Lange · 9 years ago

Advance Auto Parts Q2 Earnings Stall Out

When Advance Auto Parts released its second-quarter financial results before the markets opened on Tuesday, the company continued the trend of a sinking bottom line in the auto parts industry.

Chris Lange · 9 years ago

Monday’s Biggest Winners and Losers in the S&P 500

Monday was an incredible day for the U.S. broad markets with each index posting an incredible gain on the day. In particular the S&P 500 saw a gain in each one of its sectors.…

Chris Lange · 9 years ago

SORL Auto Misses Earnings, Could Use a Tune Up

SORL Auto Parts released its second-quarter financial results before the markets opened on Monday. Unfortunately, results were not up to par and investors sent the shares lower.

Chris Lange · 9 years ago

Zynerba Midstage Cannabinoid Trial Falls Short

Zynerba Pharmaceuticals saw its shares sink to a 52-week low after the firm announced results from its midstage trial evaluating cannabidiol gel for the treatment of knee pain due to osteoarthritis.

Chris Lange · 9 years ago

Vencore Closes In on IPO

Vencore Holding has registered amended its filing with the SEC for its initial public offering valued up to $250 million.

Chris Lange · 9 years ago

Yogaworks Cuts IPO Valuation by Nearly a Third

Yogaworks dropped the valuation for its IPO by nearly one-third. After seeing how a few other IPOs have fared this summer, taking a step back in valuation might not be that bad of an…

Chris Lange · 9 years ago